Equities

Sumitomo Pharma Co Ltd

Sumitomo Pharma Co Ltd

Actions
  • Price (EUR)3.48
  • Today's Change0.02 / 0.58%
  • Shares traded90.00
  • 1 Year change+37.01%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 18:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments36,132163,652238,580
Total Receivables, Net97,23998,630151,500
Total Inventory115,35094,40599,021
Prepaid expenses------
Other current assets, total20,84825,17310,420
Total current assets269,569381,860499,521
Property, plant & equipment, net57,89558,90964,091
Goodwill, net199,783209,415195,144
Intangibles, net195,652329,314398,692
Long term investments161,711134,007115,844
Note receivable - long term6,8466,0425,538
Other long term assets2,4894,3506,527
Total assets907,5061,134,7421,308,007
LIABILITIES
Accounts payable20,76513,40322,455
Accrued expenses------
Notes payable/short-term debt174,58890,5885,025
Current portion long-term debt/capital leases114,7104,66025,832
Other current liabilities, total205,411264,043225,061
Total current liabilities515,474372,694278,373
Total long term debt138,566251,124254,510
Total debt427,864346,372285,367
Deferred income tax38,21136,50526,550
Minority interest733365,681
Other liabilities, total59,11967,63775,005
Total liabilities751,443727,993700,119
SHAREHOLDERS EQUITY
Common stock22,40022,40022,400
Additional paid-in capital----16,725
Retained earnings (accumulated deficit)(22665)280,999514,210
Treasury stock - common(682)(682)(681)
Unrealized gain (loss)64,52639,26023,838
Other equity, total92,48464,77231,396
Total equity156,063406,749607,888
Total liabilities & shareholders' equity907,5061,134,7421,308,007
Total common shares outstanding397397397
Treasury shares - common primary issue0.610.610.61
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.